My opinion on the presentation I carefully read one more time the presention by TLN. Of all the infected patients who toll the drug, none of them die, and most of the patients are uner 2 years old ( 60 % ).The German Ecoli incidence reported 50 deaths. Gio pointed out the drug works on mice. There is ongoing analysis further on the Shigamad, even though the number of particated patients is small. I am confident there is something
in Shigamad that will reduce the risk of E. Coli infection, that is already a good sign knowing that there is nothing available in the market to cure this disease. Just keep our faith high we will arrive there folks.